-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The pathogenesis of COVID-19 is based on a delicate balance between positive and negative effects on the host's immune
COVID-19 immunity due to the interplay between chronic inflammation, the immune response against the virus, and the effects of the immunomodulatory drugs the patient is using more complicated in patients
Diagnostic Statistics
A total of 122 patients (mean age, 43.
ulcerative colitis
Figure: Risk factors for exacerbation of new coronary pneumonia
Figure: Risk factors for exacerbation of new coronary pneumonia New coronary pneumoniaThis retrospective observational study of COVID-19 patients with inflammatory bowel disease and SARS-CoV-2 infection showed that severe inflammatory bowel disease activity was the only independent risk factor for disease exacerbation in COVID-19
This retrospective observational study of COVID-19 patients with inflammatory bowel disease and SARS-CoV-2 infection showed that severe inflammatory bowel disease activity was the only independent risk factor for disease exacerbation in COVID-19
Original source:
Fabio Salvatore Macaluso.
Fabio Salvatore Macaluso.
Et al.
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
Inflammatory Bowel Diseases.
2022.
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
Leave a comment here